GLP-1 Combo Stack
Amylin and GLP-1 receptor agonists for metabolic pathway research.
$145.00
- • Cagrilintide
- • Semaglutide
$145.00
For research use only. Not for human consumption. Products are intended for laboratory and research purposes.
Cagrilintide and Semaglutide bundled for research programmes studying combined amylin-GLP-1 pathway interactions and metabolic signalling mechanisms.
Studied outcomes
A dual amylin / GLP-1 research combination. Cagrilintide (amylin pathway) and Semaglutide (a GLP-1 receptor agonist) are studied together for complementary appetite- and glycemic-signalling pathways in pre-clinical metabolic research.
Protocol notes
Handle both compounds in accordance with published pre-clinical and clinical research protocols. Reconstitute each peptide separately in an appropriate sterile research solvent.